Services

Toxicology

Pharmacology

Animal Model Development

Medical Device Testing

In Vitro Screening

Custom Assay Development

Vivarium Rental

Histology

Therapeutic Areas

Oncology

Immunology & Inflammation

Neurology / CNS

Cardiovascular

Dermatology & Wound Healing

Metabolism

Gastroenterology

Hepatology

Pulmonology

Infectious Diseases & Sepsis

Musculoskeletal

Nephrology & Urology

Species

Non-human Primates

Dogs

Minipigs / Pigs

Rabbits

Mice

Rats

Sheep

Guinea Pigs

Hamsters

Other Species

Capabilities

GLP / IND-Enabling Studies

Small and Large Animal Housing

Bioanalytical Platforms

About

News

Contact

Careers

Request a Quote

Logo
☰
  • Services ⌄
    • Toxicology
    • Pharmacology
    • Animal Model Development
    • Medical Device Testing
    • In Vitro Screening
    • Custom Assay Development
    • Vivarium Rental
    • Histology
  • Therapeutic Areas ⌄
    • Oncology
    • Immunology & Inflammation
    • Neurology / CNS
    • Cardiovascular
    • Dermatology & Wound Healing
    • Metabolism
    • Gastroenterology
    • Hepatology
    • Pulmonology
    • Infectious Diseases & Sepsis
    • Musculoskeletal
    • Nephrology & Urology
  • Species ⌄
    • Non-human Primates
    • Dogs
    • Minipigs / Pigs
    • Rabbits
    • Mice
    • Rats
    • Sheep
    • Guinea Pigs
    • Hamsters
    • Other Species
  • Capabilities ⌄
    • GLP / IND-Enabling Studies
    • Small and Large Animal Housing
    • Bioanalytical Platforms
  • About ⌄
    • News
  • Contact ⌄
    • Careers
    • Request a Quote

Law Firm Seeks to Reopen Fraud Case Against Allergan Subsidiary

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:Drug Industry Daily

A Washington, D.C. law firm petitioned the U.S. Attorney’s Office in Boston to reopen an investigation of Forest Laboratories, claiming the company misrepresented clinical trial results used as the basis…

Continue ReadingLaw Firm Seeks to Reopen Fraud Case Against Allergan Subsidiary

ViiV Healthcare Sues Gilead for Patent Infringement Following Approval of HIV Drug

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:Drug Industry Daily

ViiV Healthcare filed a patent infringement complaint against Gilead’s new HIV drug Biktarvy on the same day the combination drug secured the FDA’s approval. Source: Drug Industry Daily

Continue ReadingViiV Healthcare Sues Gilead for Patent Infringement Following Approval of HIV Drug

FDA Publishes 57 Product-Specific Guidances for Generics

  • Post author:Sam
  • Post published:February 8, 2018
  • Post category:Drug Industry Daily

The FDA issued 35 new draft and 22 revised product-specific guidances for generic drugs, including the pain treatment buprenorphine, the skin disorder treatment fluocinonide and the multiple myeloma drug ixazomib…

Continue ReadingFDA Publishes 57 Product-Specific Guidances for Generics

Madrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

MGL-3196 was well-tolerated with primarily mild and some moderate AEs. Source: BioSpace

Continue ReadingMadrigal's Cholesterol Drug Succeeds in Mid-Stage Trial

Interview Insider: Tips on How to Get Hired at Five Prime Therapeutics

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

A look at Five Prime, what they do and what they look for in hiring. Source: BioSpace

Continue ReadingInterview Insider: Tips on How to Get Hired at Five Prime Therapeutics

Bay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Rani said the latest funding round brings its coffers a total of $142M. Source: BioSpace

Continue ReadingBay Area's Rani Therapeutics Lands $53M as Company Moves to Clinical Trials

Cancer Biotech Novocure Scores New $150M Debt Financing

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The cash will be used to to execute core strategies of driving commercial adoption of Optune and advancing the clinical pipeline. Source: BioSpace

Continue ReadingCancer Biotech Novocure Scores New $150M Debt Financing

Teva Continues Restructuring With 46 Cuts in Pennsylvania

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

The cuts were apparently announced in late January with a WARN notice filed with the state. Source: BioSpace

Continue ReadingTeva Continues Restructuring With 46 Cuts in Pennsylvania

Sanofi Abandons Multiple Mid-Stage Drug Programs

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Sanofi is ending a mid-stage program for isatuximab for acute lymphoblastic leukemia, and SAR428926, an anti-LAMP1 ADC for solid tumors. Source: BioSpace

Continue ReadingSanofi Abandons Multiple Mid-Stage Drug Programs

Arbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility

  • Post author:Sam
  • Post published:February 7, 2018
  • Post category:BioPharma

Arbutus said it was undertaking the restructuring in order to better align its hepatitis B business in Warminster, Penn. Source: BioSpace

Continue ReadingArbutus Cuts 31% of Global Workforce, to Shutter Its Burnaby Facility
  • Go to the previous page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • …
  • 26
  • Go to the next page

Stay Connected

Keep up with the latest news & insights.

Contact Us

Phone:
+1 858-605-5882
Fax:
+1 858-605-5916
Email:
info@biolegacyresearch.com
Mail:
6042 Cornerstone Court W
Suite E
San Diego, CA 92121
Social::
© 2025 BioLegacy Research. All rights reserved.
BioLegacy research is a PharmaLegacy Laboratories company